119 related articles for article (PubMed ID: 2584711)
41. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
[TBL] [Abstract][Full Text] [Related]
42. Immune complex clearance by complement receptor type 1 in SLE.
Kavai M
Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
[TBL] [Abstract][Full Text] [Related]
43. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
Craig ML; Waitumbi JN; Taylor RP
J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
[TBL] [Abstract][Full Text] [Related]
44. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
Yokoyama I; Waxman F
Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
[TBL] [Abstract][Full Text] [Related]
45. In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.
Kimberly RP; Edberg JC; Merriam LT; Clarkson SB; Unkeless JC; Taylor RP
J Clin Invest; 1989 Sep; 84(3):962-70. PubMed ID: 2527255
[TBL] [Abstract][Full Text] [Related]
46. Measurement of circulating immune complexes containing IgG, IgM, IgA and IgE by flow cytometry: correlation with disease activity in patients with systemic lupus erythematosus.
Kingsmore SF; Thompson JM; Crockard AD; Todd D; McKirgan J; Patterson C; Fay AC; McNeill TA
J Clin Lab Immunol; 1989 Sep; 30(1):45-52. PubMed ID: 2534927
[TBL] [Abstract][Full Text] [Related]
47. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
Cosio FG; Shen XP; Hebert LA
Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
[TBL] [Abstract][Full Text] [Related]
48. Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor.
Yokoyama I; Waxman F
Mol Immunol; 1992; 29(7-8):935-47. PubMed ID: 1386141
[TBL] [Abstract][Full Text] [Related]
49. Defective immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with mixed essential cryoglobulinemia type II.
Madi N; Steiger G; Estreicher J; Schifferli JA
J Immunol; 1991 Jul; 147(2):495-502. PubMed ID: 2071892
[TBL] [Abstract][Full Text] [Related]
50. Zinc ions inhibit factor I-mediated release of CR1-bound immune complexes and degradation of cell-bound complement factors C3b and C4b.
Jepsen HH; Teisner B; Svehag SE
Scand J Immunol; 1990 Apr; 31(4):397-403. PubMed ID: 2139734
[TBL] [Abstract][Full Text] [Related]
51. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
Taylor RP; Horgan C; Hooper M; Burge J
J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
[TBL] [Abstract][Full Text] [Related]
52. Quantitative determination of anti-dsDNA antibodies and antibody/dsDNA stoichiometries in prepared, soluble complement-fixing antibody/dsDNA immune complexes.
Taylor RP; Horgan C
Mol Immunol; 1984 Oct; 21(10):853-62. PubMed ID: 6334233
[TBL] [Abstract][Full Text] [Related]
53. The covalent interaction of C3 with IgG immune complexes.
Vivanco F; Muñoz E; Vidarte L; Pastor C
Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
[TBL] [Abstract][Full Text] [Related]
54. Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.
Horgan C; Taylor RP
Arthritis Rheum; 1984 Mar; 27(3):320-9. PubMed ID: 6546694
[TBL] [Abstract][Full Text] [Related]
55. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes.
Gibson NC; Waxman FJ
Clin Immunol Immunopathol; 1994 Feb; 70(2):104-13. PubMed ID: 8299225
[TBL] [Abstract][Full Text] [Related]
56. C3b binding immune complexes and immunoconglutinins in human sera. Detection by enzyme-linked immunosorbent assay (ELISA).
Hautanen A; Linder E
J Immunol Methods; 1979; 30(4):367-80. PubMed ID: 512366
[TBL] [Abstract][Full Text] [Related]
57. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
Iida K; Mitomo K; Fujita T; Tamura N
J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
[TBL] [Abstract][Full Text] [Related]
58. The C(H)1 domain of IgG is not essential for C3 covalent binding: importance of the other constant domains as targets for C3.
Muñoz E; Vidarte L; Casado MT; Pastor C; Vivanco F
Int Immunol; 1998 Feb; 10(2):97-106. PubMed ID: 9580208
[TBL] [Abstract][Full Text] [Related]
59. A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes.
Oudin S; Libyh MT; Goossens D; Dervillez X; Philbert F; Réveil B; Bougy F; Tabary T; Rouger P; Klatzmann D; Cohen JH
J Immunol; 2000 Feb; 164(3):1505-13. PubMed ID: 10640768
[TBL] [Abstract][Full Text] [Related]
60. Clearance kinetics of soluble pre-formed immune complexes containing IgM antibodies in normal and decomplemented rabbits.
Harkiss GD; Brown DL
Immunology; 1981 Feb; 42(2):297-306. PubMed ID: 7461732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]